Home/Filings/4/0001213900-18-017637
4//SEC Filing

Vitolo Ottavio V. 4

Accession 0001213900-18-017637

CIK 0001553643other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 4:57 PM ET

Size

5.4 KB

Accession

0001213900-18-017637

Insider Transaction Report

Form 4
Period: 2018-12-20
Vitolo Ottavio V.
Chief Medical Officer
Transactions
  • Award

    Options to purchase common stock

    2018-12-20$1.15/sh+400,000$460,000400,000 total
    Exercise: $1.15Exp: 2028-12-20Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]Pursuant to the terms of the company's 2014 Stock Option and Equity Incentive Plan, 6.25% of the options shall vest each quarter from the date of grant.

Issuer

RELMADA THERAPEUTICS, INC.

CIK 0001553643

Entity typeother

Related Parties

1
  • filerCIK 0001736257

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:57 PM ET
Size
5.4 KB